Walker's Research Business Information
A publisher of Business Information since 1983  
  
 
Search Business Search Executive   Advanced Search
 
Sign In  |  Hints

Profile of Andrew Protter
 

Andrew Protter

 
VP, Preclinical Development - Medivation Inc.
 
Andrew Protter Email :
Please login
 
Company Name : Medivation Inc.
 
Company Website : www.medivation.net
 
Company Address : 55 Hawthorne St.
Ste. 610, San Francisco, CA,
United States,
 
Andrew Protter Profile :
VP, Preclinical Development - Medivation Inc.
 
Andrew Protter Biography :

Dr. Protter joined Medivation in September 2006 following a 24-year career at Scios, Inc., where he served most recently as vice president, biology, from 2003 to 2006. At Scios, which was acquired in 2003 by Johnson & Johnson, Dr. Protter had responsibility for all preclinical development activities for Natrecor®, a recombinant protein approved by the FDA in 2001 to treat acute decompensated congestive heart failure, and for multiple small-molecule product candidates. In recognition of his work, Dr. Protter was awarded the 2004 Johnson Medal for Natrecor research and development. Dr. Protter has published extensively in the fields of natriuretic peptides, lipid transport and intracellular kinases regulating inflammation, pain and fibrosis. He received a Ph.D. in biochemistry from the State University of New York, Stony Brook.

 
Andrew Protter Colleagues :
Name Title Email

David Hung

Board Dir., Pres., CEO Please login

Patrick MacHado

Sr. VP, CFO Please login

Lynn Seely

Chief Medical Officer Please login

Sue Wollowitz

VP, Chemistry, Manufacturing Please login

Lisa Taylor

VP, Commercial Development Please login


            Home  |  About Us  |  Product Information   |  Subscription  |  List Builder   |  Executive List   |  Email Lists   |  Contact Us  |  Site Map  |  Browse Directory   
 

© 2009, Walkers's Research - A publisher of Business Information since 1983, All Rights Reserved.